SCREENING GESTATIONAL DIABETES MELLITUS WITH NF-kB POLYMORPHISM AND GLOBAL DNA METHYLATION I
Main Article Content
Keywords
Gestational Diabetes Mellitus, NF-kB Polymorphism, DNA Methylation
Abstract
Inroduction: Gestational diabetes mellitus has emerged as a global public health problem with an exceptionally high estimated prevalence.The addition of biomarkers to predictive models of GDM may improve the ability to identify women at risk of GDM prior to its development.
Setting: SCB Medical College, Cuttack, Odisha, India.
Objective: To study the role of NF-kB and DNA-methylation as biomarkers in gestational diabetes mellitus.
Material And Method: Eligible participants were >18 years old with singleton pregnancy, plan to carry the pregnancy to term, and planned to deliver at our institution.Data was collected using in-person interviews and antenatal checkups. Information was collected on sociodemographic characteristics The study was a prospective observational study and enrolled 100 pregnant women after screening for the exclusion criterias. DNA extraction followed by Restriction fragment Length Polymorphism (RFLP) and DNA-methylation quantification was done in Molecular research unit (MRU).
Results and Conclusion: We found the prevalence of GDM to be 34%.Three types of polymorphism were found. The most common type was ins/ins type (53%) followed by del/del type (32%) and ins/del type in only 15 %..This study provides the evidence that NF-kB polymorphism and global DNA-methylation has no predictive value for screening GDM.
References
2. Kayal A, Anjana RM, Mohan V. Gestational diabetes-An update from India, 2013. Diabetes Voice 58, 2013. Available from: http://www.idf.org/gestational. diabetes .
3. Dias, S.; Pheiffer, C.; Abrahams, Y.; Rheeder, P.; Adam, S. Molecular Biomarkers for Gestational Diabetes Mellitus. Int. J. Mol. Sci. 2018, 19, 2926.
4. Smith, C.J.; Ryckman, K.K. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes Metab. Syndr. Obes. 2015, 8, 295–302.
5. Pinel C, Prainsack B, McKevitt C. Markers as mediators: a review and synthesis of epigenetics literature. Biosocieties 2019;13:276-303.
6. Farrar D, Duley L, Medley N, et al. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. 2015;1:CD007122.
7. Mishra S, Bhadoria AS, Kishore S, Kumar R. Gestational diabetes mellitus 2018 guidelines: An update. J Family Med Prim Care. 2018 Nov-Dec;7(6):1169-1172. doi: 10.4103/jfmpc.jfmpc_178_18.
8. Enquobahrie DA, Williams MA, Qiu C, Luthy DA Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract. 2005 Nov; 70(2):134
9. Shapshak P. (2012) Bioinformation and molecule of the month: multiple interactive pathways for a single gene, NF-κB. Bioinformation 8:399–402
10. Ho E, Bray TM. Antioxidants, nfkappab activation, and diabetogenesis. Proc Soc Exp Biol Med. 1999;222(3):205-13 , http://dx.doi.org/10.1046/j.1525-1373.1999.d01-137.
11. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.N Engl J Med. 1997 Apr 10; 336(15):1066-71
12. Perkins ND. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8:49–62
13. Tak, P P, and G S Firestein. “NF-kappaB: a key role in inflammatory diseases.” The Journal of clinical investigation vol. 107,1 (2001): 7-11. doi:10.1172/JCI11830
14. Cao S, Zhang X, Edwards JP, et al. (2006) NF-kappa B1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 281:26041– 26050
15. Chen L, Chen R, Wang H, Liang F. Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol. 2015;2015:508409. doi: 10.1155/2015/508409.
16. Wang, Xunli et al. “A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.” Genetic testing and molecular biomarkers vol. 19,3 (2015): 167-71. doi:10.1089/gtmb.2014.0271
17. Park JY, Farrance IK, Fenty NM, Hagberg JM, Roth SM, Mosser DM, Wang MQ, Jo H, Okazaki T, Brant SR, Brown MD Am J. NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Physiol Heart Circ Physiol. 2007 Oct; 293(4):H23207.
18. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004 Jan 1; 13(1):35-45.[
19. Chen F, Castranova V, Shi X, Demers LM New insights into the role of nuclear factorkappaB, a ubiquitous transcription factor in the initiation of diseases.Clin Chem. 1999 Jan; 45(1):7-17.
20. Plows JF et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):334
21. Patni S, Wynen LP, Seager AL, Morgan G, White JO & Thornton CA. 2009 Expression and activity of toll-like receptors 1–9 in the human term placenta and changes associated with labor at term. Biology of Reproduction 243–248. (https://doi.org/10.1095/biolreprod.108.069252)
22. Kuzmicki, M., Telejko, B., Wawrusiewicz-Kurylonek, N., Lipinska, D., Pliszka, J., Wilk, J., Zielinska, A., Skibicka, J., Szamatowicz, J., Kretowski, A., & Gorska, M. (2013). The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes, European Journal of Endocrinology, 168(3), 419-427. Retrieved Nov 15, 2020, from https://eje.bioscientifica.com/view/journals/eje/168/3/419.xml
23. Ines Mrizak, Oussama Grissa, Benoit Henault, Mariem Fekih, Ali Bouslema, Imen Boumaiza, Monia Zaouali, Zouhair Tabka and Naim A. Khan. Placental infiltration of inflammatory markers in gestational diabetic women Gen. Physiol. Biophys. (2014), .
24. Feng H, Su R, Song Y, Wang C, Lin LJ & Yang H. 2016 .Positive correlation between enhanced expression of TLR4/MyD88/NF-kappaB with insulin resistance in placentae of gestational diabetes mellitus. PLoS ONE e0157185. (https://doi.org/10.1371/journal.pone.0157185)
25. Bouchard L, Hivert MF, Guay SP, St-Pierre J, Perron P, Brisson D Diabetes. 2012 May; 61(5):1272-80.
26. El Hajj, N.; Pliushch, G.; Schneider, E.; Dittrich, M.; Müller, T.; Korenkov, M.; Aretz, M.; Zechner, U.; Lehnen, H.; Haaf, T. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 2013, 62, 1320–1328.
27. Matsha, T.E.; Pheiffer, C.; Mutize, T.; Erasmus, R.T.; Kengne, A.P. Glucose Tolerance, MTHFR C677T and NOS3G894T Polymorphisms, and Global DNA Methylation in Mixed Ancestry African Individuals. J. Diabetes Res.2016, 2016, 8738072.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Prayag Pratishriti Majhi,
Senior Resident, Dept. of O&G, PRM Medical college, Baripada, Odisha, India (Ex PG, SCB Medical College, Cuttack)
Dr Subhalaxmi Dash
Asst Professor, Dept of O&G, MKCG Medical College, Berhampur, Odisha, India
Dr Maya Padhy
Dean & Principal, SJ Medical College, Puri, Odisha, India
Dr Sudhanshu Sekhara Nanda
Asst. Professor, Dept of O&G, PRM Medical College, Baripada, Odisha, India
Dr Chintamanai Mahanta
Asso. Professor, Dept. of O&G, PRM Medical College, Baripada, Odisha